// App-Quantinova.ai

2334 : Examining the contribution of autophagy to TRAIL resistance in an in vitro model of circulating breast cancer cells

Researchers

Presenter

  • Julianne D. Twomey

Principal Investigators

  • Baolin Zhang

Medical Centers

  • U.S. Food and Drug Administration, Silver Spring, MD

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Circulating tumor cells

  • Cluster of differentiation 95

  • Sequestosome-1

  • TNF Receptor Superfamily Member 1A

  • TNF superfamily member 10

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved